Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CTAS vs GSK✓SelectedUSD · GSKCTAS vs GSK performance historyLatest closeAs of+0.50%11/20
Stock and ETF performance explorer

CTAS vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+21.3%
GSK return
+6.1%
Excess return
+15.1%
Maximum drawdown
-20.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.5%-0.1%+0.6%+0.5%
7D-2.8%-5.3%+2.6%-1.3%
30D+0.2%-3.7%+3.8%+1.1%
3M+8.4%-7.3%+15.6%+10.4%
6M+29.0%-4.2%+33.3%+30.4%
YTD+18.1%+0.9%+17.3%+18.4%
1Y+21.3%+7.3%+14.0%+19.9%
All+21.3%+6.1%+15.1%+19.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling